Latest News

Griffon’s quarter, guidance, and new joint venture Griffon (GFF) stock is in focus after the company reported first quarter results, issued 2026 revenue guidance of US$1.8b, announced a new global tools joint venture with ONCAP, and affirmed its regular cash dividend. See our latest analysis for Griffon. Griffon’s recent earnings release, 2026 revenue guidance of US$1.8b, and the new ONCAP joint venture have coincided with building momentum, with a 30 day share price return of 13.23% and a 5...

In late January 2026, Joby Aviation raised roughly US$1.20 billion through a completed US$600 million follow-on common stock offering and US$600 million of 0.75% senior subordinated unsecured convertible notes due February 15, 2032. This mix of equity and long-dated convertible debt materially boosts Joby’s funding for eVTOL certification and production while increasing dilution and capital structure complexity for shareholders. Against this backdrop, we’ll examine how Joby’s large blended...

BASF (XTRA:BAS) is back in focus after recent share price moves. This invites a closer look at how its current valuation lines up with its size, earnings profile and broader total return record. See our latest analysis for BASF. Recent trading has been firm, with a 7 day share price return of 6.83% and a 30 day gain of 9.50% at a latest share price of €49.1. However, the 1 year total shareholder return of 6.97% and 5 year total shareholder return of 0.04% suggest momentum has been relatively...

COLOPL (TSE:3668) opened fiscal 2026 with Q1 revenue of ¥4,772 million and basic EPS of ¥1.32, while on a trailing twelve month basis the company recorded revenue of ¥25,391 million and a basic EPS loss of ¥1.40. Over the last five reported quarters, revenue has moved between ¥4,772 million and ¥8,729 million, with quarterly EPS ranging from a loss of ¥10.71 to a profit of ¥2.30, so investors are watching how these shifts flow through to margins and the path back toward consistent...

Quarterly results put REA Group in focus REA Group (ASX:REA) has moved into the spotlight after its latest quarterly update, with revenue and EBITDA growth reported despite softer property listings, drawing attention to its pricing power and business resilience. See our latest analysis for REA Group. The quarterly update comes after a mixed period for investors, with a 1 day share price return of 2.61% to A$182.39 contrasting with a 1 year total shareholder return decline of 27.73% and a 3...

AXT (NasdaqGS:AXTI) is supplying Indium Phosphide substrate wafers for AI driven data center build outs as demand for advanced optical and high speed connectivity rises. The company is leveraging its established sourcing and pricing approach in a sector that combines high growth potential with elevated operational and geopolitical risks. AXT recently updated its board structure, with Leonard J. LeBlanc now classified as an independent director and appointed Chair of the Audit...

AbCellera Biologics recently highlighted its transition from a service-focused antibody discovery platform to a clinical-stage biotech, with proprietary candidates ABCL635 and ABCL575 now in Phase 1 trials and more than 100 partnered programs contributing potential royalties. This shift toward owning drug assets, alongside a broad royalty portfolio that includes 18 clinical programs, marks a meaningful change in how AbCellera may create and capture value within biopharma. We’ll now examine...

Recent performance snapshot for Astec Industries (ASTE) Astec Industries (ASTE) has drawn fresh attention after a strong run over the past year, with the stock showing positive returns over the past month, past 3 months, and year to date. See our latest analysis for Astec Industries. The recent 7 day share price return of 14.29% and 30 day share price return of 17.73% build on a year to date share price return of 22.03%, while the 1 year total shareholder return of 63.86% contrasts with a...

ASML Holding (ENXTAM:ASML) reported record Q4 2025 bookings of €13.2b for its chipmaking equipment. The company announced a €12b share buyback program scheduled to run through 2028. Management cited strong demand for advanced lithography tools used in AI and data center chip production. ASML Holding, a key supplier of lithography systems used to manufacture semiconductors, is positioned at the center of the build out of AI and high performance computing infrastructure. Its advanced EUV...

Avis Budget Group has already begun consolidating its Zipcar subsidiary’s corporate operations by closing Zipcar’s Boston headquarters, cutting more than 100 roles, and shifting oversight to the parent’s New Jersey base while keeping local field and fleet teams in place to maintain service in existing markets. This move underscores Avis Budget Group’s effort to tighten costs around Zipcar, treating car-sharing as a more experimental part of its portfolio while centralizing resources for...

TOCALO Ltd (TSE:3433) has put up another solid quarter, with Q3 2026 revenue at ¥14.3b and basic EPS of ¥33.90, backed by trailing twelve month EPS of ¥146.55 on revenue of ¥56.9b. The company has seen revenue move from ¥49.6b and EPS of ¥115.99 over the trailing twelve months to Q2 2025 to ¥56.9b and EPS of ¥146.55 by Q3 2026, with net income over the same window rising from ¥6,897m to ¥8,714m. For investors, the steady expansion in revenue and earnings feeds into a picture of margins that...

Fresh guidance gives investors clearer guardrails Life Time Group Holdings (LTH) recently issued earnings guidance for the fourth quarter of 2025 and the full years 2025 and 2026, giving investors fresh revenue and profit ranges to anchor expectations. The company outlined projected Q4 2025 revenue of about $743 million to $745 million, with net income of $120 million to $123 million, alongside updated full year views that extend into 2026. See our latest analysis for Life Time Group...

Xior Student Housing (ENXTBR:XIOR) is back in focus after its 2025 earnings call, where management highlighted 5.43% like for like rental growth, 98% occupancy, and set fresh EPS growth guidance alongside new unit expansion plans. See our latest analysis for Xior Student Housing. At a share price of €28.55, Xior Student Housing has seen muted short term share price moves despite the stronger rental growth story. The 1 year total shareholder return of 3.66% decline and 5 year total shareholder...

ChemoMetec (CPSE:CHEMM) opened H1 2026 with total revenue of DKK 244.1 million, basic EPS of DKK 4.77 and net income of DKK 83.1 million, setting the tone for another closely watched update. The company has seen revenue move from DKK 208.1 million in H2 2024 to DKK 251.5 million in H1 2025 and DKK 244.1 million in H2 2025, while basic EPS over those periods shifted from DKK 3.78 to DKK 5.94 and then DKK 4.77. This gives investors a clear view of how the top and bottom lines have tracked...

Key Insights Significant control over Cyprium Metals by individual investors implies that the general public has more...

Investors who take an interest in Tasman Resources Ltd ( ASX:TAS ) should definitely note that insider Daniel Raihani...

USA Rare Earth (NasdaqGM:USAR) has secured a non binding commitment for $1.6b in U.S. government loans and grants tied to its mine and magnet projects. The company has also raised $1.5b from private investors as part of a broader funding package. USA Rare Earth is participating in the new $12b federally backed Project Vault rare earth stockpile program. Government involvement includes equity participation and a trading bloc structure with price floors for participating suppliers. USA Rare...

If you are looking at Praxis Precision Medicines and wondering whether the recent excitement is already in the price, you are not alone. The stock closed at US$303.34, with a 9.5% gain over the last 30 days, a 5.9% return year to date, a 243.8% return over 1 year, a 366.0% return over 3 years, and a 62.0% decline over 5 years. Recent company specific news has kept Praxis in focus for investors and added context to these share price moves. Headlines around its pipeline progress, regulatory...

Caesars Entertainment (CZR) is back in focus after launching Phase Two of its US$200 million overhaul of Caesars Republic Lake Tahoe, adding upgraded pool facilities, expanded meeting space and new Clique Hospitality backed dining and entertainment. See our latest analysis for Caesars Entertainment. The Phase Two announcement has arrived alongside a 6.76% 1 day share price return and a 14.56% 90 day share price return. However, the 1 year total shareholder return of 39.55% and 5 year total...

Ålandsbanken Abp (HLSE:ALBAV) has wrapped up FY 2025 with fourth quarter revenue of €55.6 million and basic EPS of €0.84, supported by trailing twelve month revenue of €218.9 million and EPS of €3.55. Over recent periods, revenue has moved from €52.7 million in Q4 2024 to €55.6 million in Q4 2025, while trailing net income has held around the mid €50 million mark. This gives investors a clearer read on the earnings run rate behind the bank’s 24.9% net margin and dividend profile. With that...

Why Agnico Eagle Mines moved onto investors’ radar Analyst commentary around Agnico Eagle Mines (NYSE:AEM) has intensified after expectations emerged that the company may outperform earnings estimates this quarter, supported by higher gold prices, robust production and an emphasis on cost control. See our latest analysis for Agnico Eagle Mines. The recent focus on earnings has come after a sharp run in the shares, with a 24.6% 90 day share price return and 13.4% 30 day move, building on a...

D-Wave Quantum (QBTS) is back in focus after a busy week that included a $20 million hardware sale to Florida Atlantic University, a $10 million enterprise cloud contract, fresh technology milestones, and plans to relocate its headquarters. See our latest analysis for D-Wave Quantum. Despite the contract wins and technology announcements, the share price has pulled back sharply. The 30 day share price return is 34.37% and the year to date share price return is 28.51%, while the 1 year total...

Patterson-UTI Energy subsidiary NexTier Completion Solutions has launched its proprietary eos™ Completions Digital Platform. The platform is designed to integrate real-time wellsite data directly into operator workflows and reduce data silos in completions operations. This launch follows the merger that combined Patterson-UTI and NexTier, expanding the company’s technology focused offerings in oilfield services. Patterson-UTI Energy, NasdaqGS:PTEN, is rolling out eos™ at a time when its...

Sanofi recently reported that its investigational oral therapy venglustat met the primary and most key secondary endpoints in the phase 3 LEAP2MONO study for type 3 Gaucher disease, showing statistically significant neurological benefits versus enzyme replacement therapy and prompting plans for global regulatory filings. The readout is particularly important because it targets neurological manifestations of GD3, an area with no approved treatments despite long-standing systemic...